Cardiovascular and Metabolic Market Research and Competitive Intelligence Leaders
by
![]() |
![]() |
![]() |
![]() |
![]() |
CVrg Full Support™
CVrg Market Strategies™
CVrg Conference™
CVrg Sentinel™
CVrg Insights™
CVrg Advisory™
Cardiovascular
Acute Coronary Syndromes
Atrial Fibrillation & Stroke Prevention in AFib
Dyslipidemia/Atherosclerosis
Heart Failure
Peripheral Arterial Disease
Pulmonary Hypertension
Venous Thrombosis
Metabolic
Chronic Kidney Disease
Non-Alcoholic Steatohepatitis
Obesity
Type 1 Diabetes
Type 2 Diabetes
CVrg Full Support™
CVrg Market Strategies™
CVrg Conference™
CVrg Sentinel™
CVrg Insights™
CVrg Advisory™
About CVrg
Our Team
Careers
Contact
Home
CardioVascular
Acute Coronary Syndromes
Atrial Fibrillation & Stroke Prevention in AFib
Dyslipidemia/Atherosclerosis
Heart Failure
Peripheral Arterial Disease
Pulmonary Hypertension
Venous Thrombosis
Metabolic
Chronic Kidney Disease
Non-Alcoholic Steatohepatitis
Obesity
Type 1 Diabetes
Type 2 Diabetes
Conferences
ACC
ERA
EASL
ADA
HF-ESC
ESC
EASD
ASN
AASLD
AHA
ASH
Jennifer joined CVrg in 2012 after completing postdoctoral training at Stanford University and received her Ph.D. in Biomedical Sciences from the University of California, San Francisco. As a former human physiology professor, her clinical expertise adds crucial insight to her competitive intelligence skillset. With strong scientific acumen and strategic planning experience for large organizations, Jennifer provides biopharma clients outstanding support in their pipeline-to-market strategies as well as co-manages CVrg.